Perry Nicole D

CIK 00016578741 companyCRESTWOOD, KY

SEC Profile

Transactions

Companies

Filings

CIK

0001657874

Recent Transactions

37 trades

Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-08-02−1,000→ 6,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-08-02$3.76/sh+1,000→ 5,847 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-08-02$63.99/sh−1,000→ 4,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-07-01$3.76/sh+1,000→ 5,847 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-07-01$64.00/sh−1,000→ 4,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-07-01−1,000→ 7,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-06-11−1,000→ 34,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-11$3.20/sh+1,000→ 5,847 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-11$61.55/sh−1,000→ 4,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-06-01−1,000→ 8,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-01$3.76/sh+1,000→ 5,847 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-01$56.40/sh−1,000→ 4,847 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-05-03$50.73/sh−1,000→ 4,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-05-03$3.76/sh+1,000→ 5,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-05-03−1,000→ 9,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-04-30$3.76/sh+1,000→ 5,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-04-30−1,000→ 10,161 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-04-30$50.00/sh−1,000→ 4,847 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-03-01−2,000→ 11,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-03-01$3.76/sh+2,000→ 4,347 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-03-01$50.00/sh−2,000→ 2,347 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-02-10$47.72/sh−153→ 2,347 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-02-09$50.00/sh−2,000→ 2,500 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-02-09$3.76/sh+2,000→ 4,500 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-02-09−2,000→ 13,161 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-28+15,000→ 15,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-28+2,500→ 2,500 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-04−2,000→ 15,161 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-04$3.76/sh+2,000→ 2,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-04$57.24/sh−2,000→ 0 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2020-12-04$3.76/sh+18,000→ 18,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2020-12-04$50.00/sh−18,000→ 0 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2020-12-04−18,000→ 17,161 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2020-02-10+2,500→ 2,500 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock option (right to buy)
2020-02-10+15,000→ 15,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock option (right to buy)
2019-02-08+22,000→ 22,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2018-02-16+25,000→ 25,000 total

Companies

Apellis Pharmaceuticals, Inc.
Vice President - Finance
$APLS

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A

CRESTWOOD, KY, 40014

View on SEC.gov